Source:http://linkedlifedata.com/resource/pubmed/id/10168546
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-8-19
|
pubmed:abstractText |
Thirty-four patients affected by mixed cryoglobulinaemia have been submitted to treatment by apheresis (plasma exchange or double cascade filtration). The authors have monitored clinical, laboratory and, above all, haemorheological changes following therapy. The final results have shown mainly a reduction of plasma viscosity and consequently an improvement of the haemorheology of the affected organs. In conclusion, apheresis may be considered a successful therapy in patients with severe renal or neurological diseases due to mixed cryoglobulinaemia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
T
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0955-3886
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
499-503
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1996
|
pubmed:articleTitle |
Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment.
|
pubmed:affiliation |
Plasmapheresis and Dialysis Unit, Institute of 1 Clinical Medica, University of Rome, La Sanienza, Italy.
|
pubmed:publicationType |
Journal Article
|